Sub-Analysis of Geographical Variations in the 2-Year Observational COPTIMIZE Trial of Patients With Relapsing–remitting Multiple Sclerosis Converting to Glatiramer Acetate
BMC Neurology - United Kingdom
doi 10.1186/s12883-015-0448-4
Full Text
Open PDFAbstract
Available in full text
Date
October 8, 2015
Authors
Publisher
Springer Science and Business Media LLC